Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2004

View Archived Issues

Caspase-3 inhibitor improves islet graft functions

Bone Care International highlights third quarter progress

Oral rhLF reduces the effects of allergen challenge in a sheep model of asthma

Bimosiamose attenuates LAR in mild allergic asthma

First success-based milestone in Syrrx and Biogen Idec collaboration

Second successful clinical study with VR-004 for erectile dysfunction

Phase IIIb trial evaluates Integrilin in early use acute coronary syndrome setting

Aventis delivers on submissions and approvals program during Q1

GlaxoSmithKline provides near-term outlook

Update on the pharmacokinetics and effects of the antiepileptic drug BIA-2-093

Topical vitamin B12 reported safe and effective in atopic dermatitis

SnET2 NDA accepted for priority review

Proposed financing at InSite to advance AzaSite development

SkyePharma and Vectura in strategic alliance for pulmonary delivery technologies

Prevacid I.V. approved for erosive esophagitis

Altachem advances phase I trial for ACP-HIP

Amrad progresses spin-out of Avexa

GlaxoSmithKline wins MMV's Project of the Year award for Pyridone

West Nile protocol with Alferon N treatment receives approval

Novel partial benzodiazepine agonist with higher tolerability and less side effects

SRI announces Bridge Pharmaceuticals spin-off

Therion cleared to conduct phase III pancreatic cancer trial of Panvac-VF

Novel PARP inhibitor shows neuroprotective activity in vivo

Nutropin Depot to be discontinued

Activity of CAT-213 investigated in vitro and in vivo

Antifibrotic effects of EM-703 studied in mice

ONO-EI-600 may offer protection against ventilator-induced lung injury

Sumitomo presents new antifungal agents from Streptomyces sp.

New antihistaminic agents under study at Japan Energy

Tanabe Seiyaku claims RANKL antagonists with utility in osteoporosis

New GLP-2 analogues for intestinal disorders designed at Novo Nordisk

New polycyclic antitumor agents prepared and tested at Banyu

Japan Energy describes novel microtubule polymerization inhibitors

New mevastatin derivatives and their use as cholesterol-lowering agents

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026